Relationship between Levels of Pre-Stroke Physical Activity and Post-Stroke Serum Insulin-Like Growth Factor I.

cerebrovascular disease insulin-like growth factor I ischemic stroke physical activity stroke stroke severity

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
04 Mar 2020
Historique:
received: 31 01 2020
revised: 28 02 2020
accepted: 02 03 2020
entrez: 8 3 2020
pubmed: 8 3 2020
medline: 8 3 2020
Statut: epublish

Résumé

Physical activity (PA) and insulin-like growth factor I (IGF-I) have beneficial effects for patients who have suffered an ischemic stroke (stroke). However, the relationship between the levels of PA and IGF-I after stroke has not been explored in detail. We investigated the pre-stroke PA level in relation to the post-stroke serum IGF-I (s-IGF-I) level, at baseline and at 3 months after the index stroke, and calculated the change that occurred between these two time-points (ΔIGF-I). Patients (

Identifiants

DOI: 10.3390/biomedicines8030052 PMID: 32143318 PMC: PMC7148508
pubmed: 32143318
pii: biomedicines8030052
doi: 10.3390/biomedicines8030052
pmc: PMC7148508
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Svenska Läkaresällskapet
ID : NA
Organisme : Hjärt-Lungfonden
ID : 20190203
Organisme : STROKE-Riksförbundet
ID : NA
Organisme : Vetenskapsrådet
ID : 2018-02543

Références

J Clin Endocrinol Metab. 2006 Oct;91(10):3928-34
pubmed: 16882751
Neurorehabil Neural Repair. 2017 Jan;31(1):65-71
pubmed: 27377914
Growth Horm IGF Res. 2011 Jun;21(3):124-8
pubmed: 21459641
Neurology. 2018 Oct 16;91(16):e1461-e1467
pubmed: 30232251
J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):466-8
pubmed: 19900650
Eur J Neurol. 2011 Feb;18(2):365-7
pubmed: 20500804
Stroke. 2000 Nov;31(11):2569-77
pubmed: 11062277
BMC Neurol. 2018 Aug 6;18(1):106
pubmed: 30081862
Clin Endocrinol (Oxf). 1994 Sep;41(3):351-7
pubmed: 7955442
Stroke. 2011 Aug;42(8):2180-5
pubmed: 21700939
Stroke. 2017 Nov;48(11):3093-3100
pubmed: 28931620
Neurology. 2017 May 2;88(18):1718-1726
pubmed: 28381510
Circulation. 1968 Dec;38(6):1104-15
pubmed: 5721960
Stroke. 1997 Sep;28(9):1744-8
pubmed: 9303019
J Endocrinol Invest. 2012 Jul;35(7):699-707
pubmed: 22714057
Am J Med. 2004 Sep 1;117(5):312-7
pubmed: 15336580
Ann Epidemiol. 2010 Mar;20(3):182-93
pubmed: 20159489
J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1800-1806
pubmed: 27113779
ScientificWorldJournal. 2006 Jan 18;6:53-80
pubmed: 16432628
J Clin Endocrinol Metab. 2011 Jul;96(7):E1055-64
pubmed: 21508132
Stroke. 2005 Jul;36(7):1383-7
pubmed: 15933254
J Neurosci. 2001 Aug 1;21(15):5678-84
pubmed: 11466439
J Rehabil Med. 2015 Aug 18;47(7):612-7
pubmed: 26073856
J Clin Endocrinol Metab. 2005 Nov;90(11):5937-41
pubmed: 16131586

Auteurs

N David Åberg (ND)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, SE-41345 Gothenburg, Sweden.
Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg SE-41345, Sweden.
ORCID: 0000-0002-1474-5666

Gustaf Gadd (G)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, SE-41345 Gothenburg, Sweden.
Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg SE-41345, Sweden.

Daniel Åberg (D)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, SE-41345 Gothenburg, Sweden.
Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg SE-41345, Sweden.

Peter Hällgren (P)

Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg SE-41345, Sweden.

Christian Blomstrand (C)

Department for Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.

Katarina Jood (K)

Department for Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.

Michael Nilsson (M)

School of Biomedical Sciences and Pharmacy and the Priority Research Centre for Stroke and Brain Injury, the University of Newcastle, University Dr, Callaghan, NSW 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, NSW 2305, Australia.

Fredrick R Walker (FR)

School of Biomedical Sciences and Pharmacy and the Priority Research Centre for Stroke and Brain Injury, the University of Newcastle, University Dr, Callaghan, NSW 2308, Australia.
Hunter Medical Research Institute, Lot 1, Kookaburra Cct, New Lambton Heights, NSW 2305, Australia.

Johan Svensson (J)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, SE-41345 Gothenburg, Sweden.

Christina Jern (C)

Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-41345 Gothenburg, Sweden.
Department of Clinical genetics and genomics, Sahlgrenska University Hospital, SE-41345 Gothenburg, Sweden.

Jörgen Isgaard (J)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, SE-41345 Gothenburg, Sweden.
School of Biomedical Sciences and Pharmacy and the Priority Research Centre for Stroke and Brain Injury, the University of Newcastle, University Dr, Callaghan, NSW 2308, Australia.

Classifications MeSH